Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Cancers|November 27, 2021
Silencing CTNND1 Mediates Triple-Negative Breast Cancer Bone Metastasis via Upregulating CXCR4/CXCL12 Axis and Neutrophils Infiltration in BoneQun Lin, Xiaolin Fang, Gehao Liang, et al.
IEEE Transactions on Neural Systems and Rehabilitation Engineering : a Publication of the IEEE Engineering in Medicine and Biology Society|September 23, 2025
Beta-Band Corticomuscular Coherence: A Novel Biomarker of Functional Corticospinal Tract Integrity and Motor Recovery After StrokeJingyao Sun, Qilu Zhang, Di Ma, et al.
IEEE Transactions on Bio-Medical Engineering|December 12, 2025
Structured and sparse partial least squares coherence for multivariate cortico-muscular analysisJingyao Sun, Qilu Zhang, Di Ma, et al.
Cancers|November 27, 2025
Correction: Lin et al. Silencing CTNND1 Mediates Triple-Negative Breast Cancer Bone Metastasis via Upregulating CXCR4/CXCL12 Axis and Neutrophils Infiltration in Bone. Cancers 2021, 13, 5703Qun Lin, Xiaolin Fang, Gehao Liang, et al.
Frontiers in Health Services|April 20, 2026
Effect of PDCA cycle on critical value management in primary healthcare institutions: an interrupted time series studyXiaolong Cui, Chen Liang, Shijie Jia, et al.
Oncology Letters|February 7, 2022
SLAMF6/Ly108 promotes the development of hepatocellular carcinoma via facilitating macrophage M2 polarizationQi Meng, Xiuyun Duan, Qingchao Yang, et al.
Biochemical Pharmacology|June 25, 2025
Identification and characterization of a potent peptide inhibitor targeting FOXM1 in cancer therapyAnping Liang, Miao Chang, Zhixian Shang, et al.
Theranostics|May 7, 2026
A peptide-based PROTAC targeting FOXM1 suppresses fibrosis-associated hepatocarcinogenesisDingyu Wu, Lei Duan, Di Tan, et al.
The Oncologist|June 30, 2023
Association of FTH1-Expressing Circulating Tumor Cells With Efficacy of Neoadjuvant Chemotherapy for Patients With Breast Cancer: A Prospective Cohort StudyShijie Jia, Yaping Yang, Yingying Zhu, et al.
Molecular Cancer|January 4, 2022
circCDYL2 promotes trastuzumab resistance via sustaining HER2 downstream signaling in breast cancerYun Ling, Gehao Liang, Qun Lin, et al.
Pageof 6